Added to YB: 2025-08-13
Pitch date: 2025-08-11
HLVX [bullish]
HilleVax, Inc.
+0.48%
current return
Author Info
BiotechBonanza shares takes on biotech with a heavy focus on special situations. Sign up for the newsletter.
Company Info
HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States.
Market Cap
$102.5M
Pitch Price
$2.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.70
P/E
-1.45
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
HLVX: A 'lease CVR' - something else for a change!
HLVX: Broken biotech taken over near net cash; CVR at 10-12¢ worth 15-30¢. Harrison lease savings via Stellaromics sublease (NPV ~14.9¢); upside from remaining 6,511 sqft (~9¢ more). Possible norovirus asset payments ($5-10M = ~18¢) despite vaccine headwinds under RFK. Risk 2¢, potential 20¢+. Target $2 entry.
Read full article (9 min)